Physician profile
Rabih Tawk
NPI 1760613988
$3,315.95
in general payments reported to CMS, 2019-2025
9 companies · $2,066 in 2025
The $2,066 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $959 · 2020: $17.68 · 2021: $14.52 · 2023: $198 · 2024: $60.31 · 2025: $2,066.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,605 · Food and Beverage: $719.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,605.35 |
| Food and Beverage | $719.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,075.28 | 2023-2025 | Pipeline, Onyx 18, Solitaire X |
| Microvention, INC. | $864.06 | 2019-2024 | Lvis Junior |
| Balt USA, LLC | $123.95 | 2023 | |
| Asahi Intecc USA, INC. | $123.06 | 2019 | |
| Stryker Corporation | $74.52 | 2021-2023 | Neuroform Atlas |
| Depuy Synthes Sales INC. | $37.40 | 2025 | Synthecel, Matrixneuro |
| Medtronic USA, INC. | $17.68 | 2020 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rabih Tawk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.